Events picture

Ellen Frank, PhD January 5, 2012, 12:00 pm UPMC Shadyside, Hillman Cancer Center, Cooper Classroom C


Sponsored by Biobehavioral Medicine in Oncology Program

Interpersonal and Social Rhythm Therapy: What a Treatment for Bipolar Disorder Might Have to Offer to Cancer Patients

Ellen Frank, PhD
Distinguished Professor of Psychiatry and Professor of Psychology
University of Pittsburgh School of Medicine

Dr. Frank and her colleagues have developed and tested a series of adaptations of interpersonal psychotherapy (IPT) including maintenance IPT, brief IPT, and interpersonal and social rhythm therapy for the treatment of bipolar disorder which has now been adapted for both group and individual treatment of bipolar and unipolar disorders. She recently completed a study with researchers at the University of Pisa, Italy, aimed at achieving a better understanding of the clinical importance of subsyndromal mood and anxiety conditions and their impact on the outcome of interpersonal psychotherapy and SSRI for depression. She is currently working with colleagues throughout France to establish a network of expert centers for the treatment of bipolar disorder.

The Cooper Classrooms are located on the ground level of the Hillman Cancer Center, 5115 Centre Ave, Shadyside. After entering the building walk to the left past the elevators and gift shop and make the first left down the hallway. Room C is the 3rd door in the lobby area.

Parking is available in the garage at the UPMC Cancer Pavilion across the street from the Hillman Cancer Center (~$6 cash/credit for 1-2 hours). There are also parking meters along Centre Avenue, Cypress Street, and Baum Boulevard in the blocks surrounding the Cancer Center. The 71A & 71C both travel from Oakland and stop at Cypress Street just beyond the Cancer Center entrance. UPMC shuttles also run between Oakland and Shadyside (

Light lunch provided.
Please contact Jessica Manculich ( if you plan to attend,
need directions, or need more information.

Sponsored by The Biobehavioral Medicine in Oncology Program, University of Pittsburgh Cancer Institute